Evidence map›Paper›PMID 26178479›Full record

ArticleInflammation2015

Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice.

Hong-Ling Wang, Yu-Xiang Li, Ya-Ting Niu, Jie Zheng, Jing Wu, Guang-Jiang Shi, Lin Ma, Yang Niu, Tao Sun, Jian-Qiang Yu

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Combined Omeprazole andInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Foods (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Immunomodulatory properties of triterpenes.Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2022
    Review
  10. Plants (Basel, Switzerland) · 2021
    Review
  11. Review
  12. The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.Phytomedicine plus : international journal of phytotherapy and phytopharmacology · 2021
    Review
  13. Review
  14. Review
  15. Concurrent production of glycyrrhetic acid 3-Bioresources and bioprocessing · 2021
    Article
  16. Liquorice for pain?Therapeutic advances in psychopharmacology · 2021
    Review
  17. Review
  18. Retrofractamide C Derived fromMolecules (Basel, Switzerland) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hong-Ling WangDepartment of Pharmacology, School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Yu-Xiang LiCollege of Nursing, Ningxia Medical University, Yinchuan, 750004, China.
Ya-Ting NiuDepartment of Pharmacology, School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Jie ZhengDepartment of Pharmacology, School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Jing WuLaboratory Animal Center, Ningxia Medical University, Yinchuan, 750004, China.
Guang-Jiang ShiDepartment of Pharmacology, School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Lin MaKey Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, 750004, China.
Yang NiuKey Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan, 750004, China.
Tao SunKey Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, 750004, China.
Jian-Qiang YuDepartment of Pharmacology, School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China. Yujq910315@163.com.
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the potential anti-inflammatory and anti-nociceptive activities of glycyrrhizin (GL) in mice and to explore the possible related mechanisms. Xylene-induced ear edema, carrageenan-induced paw edema and acetic acid-induced vascular permeability test were used to investigate the anti-inflammatory activities of GL in mice. Anti-nociceptive effects of GL were assessed by using acetic acid-induced writhing, hot plate test and formalin test, as well as evaluation of spontaneous locomotor activity and motor performance. The mRNA expression of pro-inflammatory cytokines (such as TNF-α, IL-6 and iNOS) and the protein expression of cyclooxygenase-2 (COX-2) were explored by using real-time fluorogenic PCR and Western blot, respectively. The results showed that GL significantly reduced xylene-induced ear edema, carrageenan-induced paw edema, and acetic acid-induced vascular permeation. Additionally, GL significantly inhibited the nociceptions induced by acetic acid and formalin. However, the nociceptions could not be decreased by GL in the hot plate test, and GL did not affect spontaneous locomotor activity and motor performance. The expression levels of TNF-α, IL-6, iNOS and COX-2 were significantly downregulated by GL. In conclusion, GL exerts significant anti-inflammatory and analgesic activities by attenuating the expression levels of TNF-α, IL-6, iNOS and COX-2.

Indexed as

Acetic AcidAnalgesicsAnimalsAnti-Inflammatory AgentsCapillary PermeabilityCarrageenanCyclooxygenase 2Cyclooxygenase 2 InhibitorsCytokinesDisease Models, AnimalDose-Response Relationship, DrugEdemaFormaldehydeGlycyrrhizic AcidIndomethacinInflammationAcetic AcidAnalgesicsAnti-Inflammatory AgentsCarrageenanCyclooxygenase 2Cyclooxygenase 2 InhibitorsCytokinesFormaldehydeGlycyrrhizic AcidIndomethacinInflammation MediatorsNitric Oxide Synthase Type IINos2 protein, mousePtgs2 protein, mouseXylenesanti-inflammatory activityanti-nociceptive activitycyclooxygenase-2glycyrrhizinpro-inflammatory cytokines

Identifiers

PMID26178479
OpenAlexW2124907780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.